Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Pilot study of air pollution adducts in PLCO serum samples | Katherine McGlynn | National Cancer Institute | PLCO | Feb 2, 2023 | 2023-9000 |
| Infection and immunity in uterine corpus and ovarian cancers | Kara Michels | Albert Einstein College of Medicine | PLCO | Feb 1, 2023 | 2022-0037 |
| Projecting the impact of multicancer early detection tests on stage at diagnosis: a modeling approach | JANE LANGE | OREGON HEALTH AND SCIENCES UNIVERSITY | NLST | Jan 30, 2023 | NLST-1012 |
| Perfluorooctanoic acid (PFOA) exposure, DNA methylation patterns, and renal cell carcinoma | Charles Breeze | National Cancer Institute | PLCO | Jan 19, 2023 | 2022-0036 |
| Role of Cyanobacteria and cyanotoxins in liver cancer development | Brenda Hernandez | University of Hawaii Cancer Center | PLCO | Jan 19, 2023 | 2022-0033 |
| lung nodule segmentation and shape analysis | DI XU | University of California, Los Angeles | NLST | Jan 18, 2023 | NLST-1011 |
| Missing censoring indicators in survival analysis | Mikael Escobar-Bach | Laboratoire Angevin de Recherche en Mathématiques, Université d'Angers | PLCO | Jan 18, 2023 | PLCO-1149 |
| Ovarian Cancer Detection using Menstruation and Weight/Calorie Tracking | Kavin Mohan | Queen's University | PLCO | Jan 13, 2023 | PLCO-1146 |
| Metabolomic markers of physical activity in the IDATA Study | Eleanor Watts | National Cancer Institute | IDATA | Jan 13, 2023 | IDATA-61 |
| Lung Cancer Screening and Risk Assessment | Edward Tan | iota Medtech | NLST | Jan 13, 2023 | NLST-1008 |
| Risk assessment of individuals with screen-detected lung nodules | Stephen Duffy | Queen Mary University of London | NLST | Jan 12, 2023 | NLST-1007 |
| A Deep Learning Algorithm using the PLCO data to estimate cancer risk from multiple cancers | Ping Hu | National Cancer Institute | PLCO | Jan 12, 2023 | PLCO-1142 |
| Research gaps in PSA tests and race-specific risk factors | Anwar Ahmed | Uniformed Services University | PLCO | Jan 11, 2023 | PLCO-1141 |
| Analysing non-clinical attributes of Male Breast Cancer using Machine Learning | Vaidehi Gajera | Western Sydney University | PLCO | Jan 11, 2023 | PLCO-1143 |
| Prostate Cancer Clinical Outcomes | K.C Balaji | UF Health Jacksonville | PLCO | Jan 3, 2023 | PLCO-1139 |
| Spatial and socioeconomic disparity in the colorectal cancer screening rate | Yoshito Nishimura | University of Hawaii | PLCO | Dec 27, 2022 | PLCO-1135 |
| Computational Pathology in Ovarian Cancer | Sandra Orsulic | Regents University of California Los Angeles | PLCO | Dec 19, 2022 | PLCOI-1132 |
| Indirect comparisons of screening strategies and generalizing effects to a nationally representative population by combining trial data | Issa Dahabreh | President and Fellows of Harvard College on behalf of Harvard T.H. Chan School of Public Health | PLCO | Dec 19, 2022 | PLCO-1130 |
| Meta-data for CRDC pilot study | Eric Miller | National Cancer Institute | PLCO | Dec 9, 2022 | PLCO-1128 |
| Early Warning of Ovarian Cancer | Michael Korenberg | Queen's University | PLCO | Dec 8, 2022 | PLCO-1126 |